BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29055915)

  • 1. Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack.
    Krawczyk M; Lammert F
    Ann Hepatol; 2017 November-December,; 16(6):830-831. PubMed ID: 29055915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
    Alberts R; de Vries EMG; Goode EC; Jiang X; Sampaziotis F; Rombouts K; Böttcher K; Folseraas T; Weismüller TJ; Mason AL; Wang W; Alexander G; Alvaro D; Bergquist A; Björkström NK; Beuers U; Björnsson E; Boberg KM; Bowlus CL; Bragazzi MC; Carbone M; Chazouillères O; Cheung A; Dalekos G; Eaton J; Eksteen B; Ellinghaus D; Färkkilä M; Festen EAM; Floreani A; Franceschet I; Gotthardt DN; Hirschfield GM; Hoek BV; Holm K; Hohenester S; Hov JR; Imhann F; Invernizzi P; Juran BD; Lenzen H; Lieb W; Liu JZ; Marschall HU; Marzioni M; Melum E; Milkiewicz P; Müller T; Pares A; Rupp C; Rust C; Sandford RN; Schramm C; Schreiber S; Schrumpf E; Silverberg MS; Srivastava B; Sterneck M; Teufel A; Vallier L; Verheij J; Vila AV; Vries B; Zachou K; ; Chapman RW; Manns MP; Pinzani M; Rushbrook SM; Lazaridis KN; Franke A; Anderson CA; Karlsen TH; Ponsioen CY; Weersma RK
    Gut; 2018 Aug; 67(8):1517-1524. PubMed ID: 28779025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
    Juran BD; Atkinson EJ; Schlicht EM; Larson JJ; Ellinghaus D; Franke A; Lazaridis KN
    Liver Int; 2011 Jul; 31(6):785-91. PubMed ID: 21134112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
    Alexander J; Lord JD; Yeh MM; Cuevas C; Bakthavatsalam R; Kowdley KV
    Liver Transpl; 2008 Feb; 14(2):245-51. PubMed ID: 18236405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.
    Freund C; Wahlers A; Begli NH; Leopold Y; Klöters-Plachky P; Mehrabi A; Mohr I; Sander J; Rupp C; Gotthardt DN; Weiss KH
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):646-652. PubMed ID: 31928970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of liver transplantation in children with primary sclerosing cholangitis.
    Venkat VL; Ranganathan S; Sindhi R
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):289-94. PubMed ID: 25592492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis.
    Goet JC; Floreani A; Verhelst X; Cazzagon N; Perini L; Lammers WJ; de Vries AC; van der Meer AJ; van Buuren HR; Hansen BE
    J Hepatol; 2019 Nov; 71(5):992-999. PubMed ID: 31278949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
    Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
    Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
    Henson JB; Patel YA; Wilder JM; Zheng J; Chow SC; King LY; Muir AJ
    Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
    Tamura S; Sugawara Y; Kaneko J; Matsui Y; Togashi J; Makuuchi M
    Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis - a comprehensive review.
    Karlsen TH; Folseraas T; Thorburn D; Vesterhus M
    J Hepatol; 2017 Dec; 67(6):1298-1323. PubMed ID: 28802875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis.
    Zhang CC; Voitl R; Hippchen T; Weiss KH; Sauer P; Rupp C
    Scand J Gastroenterol; 2020 May; 55(5):581-587. PubMed ID: 32329406
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and clinical spectrum of primary sclerosing cholangitis.
    Gidwaney NG; Pawa S; Das KM
    World J Gastroenterol; 2017 Apr; 23(14):2459-2469. PubMed ID: 28465630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.
    Eksteen B
    Br Med Bull; 2014 Jun; 110(1):89-98. PubMed ID: 24795363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
    Sheth S; Shea JC; Bishop MD; Chopra S; Regan MM; Malmberg E; Walker C; Ricci R; Tsui LC; Durie PR; Zielenski J; Freedman SD
    Hum Genet; 2003 Aug; 113(3):286-92. PubMed ID: 12783301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis.
    Martin EF; Levy C
    Semin Liver Dis; 2017 Nov; 37(4):305-313. PubMed ID: 29272893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for primary sclerosing cholangitis.
    Gow PJ; Chapman RW
    Liver; 2000 Apr; 20(2):97-103. PubMed ID: 10847476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
    de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
    Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.